About BREFFI
BREFFI is a company based in Moscow (Russia) founded in 2012. BREFFI has raised $10.19 million across 1 funding round from investors including Elbrus Capital. BREFFI operates in a competitive market with competitors including Zevra, Sayre Therapeutics, Supreme Optimization, Andira and Life Science Connect, among others.
- Headquarter Moscow, Russia
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.19 M (USD)
in 1 rounds
-
Latest Funding Round
$10.19 M (USD), Series B
Dec 29, 2021
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BREFFI
BREFFI has successfully raised a total of $10.19M through 1 strategic funding round. The most recent funding activity was a Series B round of $10.19 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BREFFI
BREFFI has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Elbrus Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sector
|
Locked | Locked | Locked |
Investor details for BREFFI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BREFFI
Investment portfolio details for BREFFI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BREFFI
Detailed financials for BREFFI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Breffi Comparisons
Peer comparison for BREFFI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BREFFI
BREFFI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zevra, Sayre Therapeutics, Supreme Optimization, Andira and Life Science Connect, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Marketing services are provided to biopharma companies.
|
|
| Locked | Locked | Locked |
Access to therapies for rare and life-threatening diseases is provided.
|
|
| Locked | Locked | Locked |
Digital marketing services are offered to the life sciences sector.
|
|
| Locked | Locked | Locked |
Digital pharmacotherapeutic platform for providers
|
|
| Locked | Locked | Locked |
Marketing and commercialization services for biopharma sector are provided.
|
|
| Locked | Locked | Locked |
A pharmaceutical marketing company with a network in Delhi-NCR and UP.
|
Detailed competitors of BREFFI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Breffi
Complete news archive for BREFFI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BREFFI
BREFFI was founded in 2012 and raised its 1st funding round 9 years after it was founded.
BREFFI is headquartered in Moscow, Russia.
BREFFI is a funded company, having raised a total of $10.19M across 1 funding round to date.
BREFFI was established in 2012 in Moscow, Russia, as a provider of market research services targeted at the biopharma industry. Operations are centered in Moscow, where data analysis, competitive intelligence, and strategic insights are delivered to clients in the pharmaceutical and biotechnology sectors. Services encompass market assessments, trend forecasting, and regulatory analysis, supporting decision-making processes for biopharma entities operating in Russia and internationally.
BREFFI's top competitors include Zevra, Sayre Therapeutics and Life Science Connect.
BREFFI has 1 investor. Key investors include Elbrus Capital.